Shilpa Chandel

Shilpa Chandel

Active Director Director DIN 08359193
DIN 08359193 First appointment May 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 13 active board seats
Total affiliations 13 Since May 2019
Shareholding value •••• Premium profile

About Shilpa Chandel

Data last updated:

Shilpa Chandel is a Director at Mits Healthcare Private Limited (since 2024), Director at Shinepro Life Sciences Private Limited (since 2021) and Director at Mits Natura Limited (since 2022), and holds 10 more current directorships. The companies operate in Pharma, Healthcare and Information Technology. The 6 current companies with reported revenue have a combined latest revenue of ₹35.50 Cr; the largest is Mits Healthcare Private Limited at ₹26.04 Cr (FY 2024).

DIN 08359193
Primary Designation Director
Industry Pharma
First Appointment 23 May 2019
Oldest Company Age 16 yrs
Largest company Mits Healthcare Private Limited · ₹26.04 Cr (FY 2024)
Combined revenue ₹35.50 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mits Healthcare Private Limited U74999UP2010PTC040798
Director07 Aug 20242010₹26.04 Cr (FY 2024)Active
Director16 Sep 20212021₹6.58 Cr (FY 2024)Active
Mits Natura Limited U24290HR2022PLC104040
Director30 May 20222022₹2.06 Cr (FY 2025)Active
Mits Digitech Limited U72900HR2022PLC103539
Director11 May 20222022₹44.6 Lakh (FY 2025)Active
Director11 Jun 20242024₹25.9 Lakh (FY 2025)Active
Mits Entertainment Limited U92100HR2022PLC101916
Director10 Mar 20222022₹11.7 Lakh (FY 2025)Active
Mits Automobiles Private Limited U29300HR2024PTC124039
Director08 Aug 20242024Active
Spira Lifesciences Private Limited U21000HR2024PTC123155
Director08 Jul 20242024Active

Directorship timeline

Open interactive timeline →
Shinepro Life Sciences Private Limited
Mits Spectra Life Care Private Limited
Mits Natura Limited
Mits Aviation Limited
Premium access

Shareholding and investment profile for Shilpa Chandel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shilpa Chandel

Shilpa Chandel currently holds 13 directorships: Mits Healthcare Private Limited (Director, since 07 Aug 2024, revenue ₹26.04 Cr (FY 2024)); Shinepro Life Sciences Private Limited (Director, since 16 Sep 2021, revenue ₹6.58 Cr (FY 2024)); Mits Natura Limited (Director, since 30 May 2022, revenue ₹2.06 Cr (FY 2025)); Mits Digitech Limited (Director, since 11 May 2022, revenue ₹44.6 Lakh (FY 2025)); Zubinext Lifesciences Private Limited (Director, since 11 Jun 2024, revenue ₹25.9 Lakh (FY 2025)); and 8 more.

Shilpa Chandel was first appointed on 23 May 2019 as Director at Mits Spectra Life Care Private Limited. The most recent appointment on record is 08 Aug 2024 at Mits Automobiles Private Limited.

The 6 current companies of Shilpa Chandel that report revenue have a combined latest revenue of ₹35.50 Cr: Mits Healthcare Private Limited ₹26.04 Cr (FY 2024); Shinepro Life Sciences Private Limited ₹6.58 Cr (FY 2024); Mits Natura Limited ₹2.06 Cr (FY 2025); Mits Digitech Limited ₹44.6 Lakh (FY 2025); Zubinext Lifesciences Private Limited ₹25.9 Lakh (FY 2025); and 1 more.

The current boards of Shilpa Chandel's companies include Bilal Ahamad (Mits Healthcare Private Limited), Mithoon Bhatia (Mits Healthcare Private Limited), Priyanka (Shinepro Life Sciences Private Limited), Aakriti Raina (Shinepro Life Sciences Private Limited), Gitanjli (Shinepro Life Sciences Private Limited), Nirdosh (Mits Natura Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available